Why the study?
Do nonpharmacological and pharmacological therapies improve endothelial function in patients with cardiovascular disease?
Do nonpharmacological and pharmacological therapies improve endothelial function in patients with cardiovascular disease?
This review highlights the importance of early detection and treatment of endothelial dysfunction using lifestyle modifications and specific pharmacological agents to prevent or treat arteriosclerosis.
Supports endothelial repair strategies in CVD; leaves open need for randomized outcome trials before practice change.
Vascular endothelial dysfunction reflected by reduced nitric oxide (NO) availability is certainly the causative factor or promoting mechanism of arteriosclerosis. It is necessary to detect endothelial dysfunction at an early stage using appropriate methods, and to choose a treatment for the recovery of endothelial function. There are nonpharmacological and pharmacological therapies to attain endothelial repair. The former includes body weight reduction, aerobic exercise, and restriction of salt intake, while the latter includes the use of renin-angiotensin system inhibitors, calcium antagonists, some types of beta blockers, statins, erythropoietin, tetrahydrobiopterin, and antioxidants. These therapies are intended to increase NO synthase activity and NO release, inhibit NO degradation, and enhance the activity of endothelial progenitor cells.
No takes yet. Share an insight, caveat, or question.
Hirata et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: